Skip to main content

Advertisement

Table 1 Comparison of NUSTART recruitment characteristics of patients followed-up at 2–3 years post-ART initiation versus those not followed-up (due to loss to follow-up, lack of data or death)a

From: Dysglycemia associations with adipose tissue among HIV-infected patients after 2 years of antiretroviral therapy in Mwanza: a follow-up cross-sectional study

  Followed-up at 2–3 years post ART (n = 273) Lost to follow-up or died before 2–3 years-post ART (n = 431) P-valueb
Lost to follow-up (n = 145) Died (n = 286)
Age at baseline, year 38.9 (9.7) 35.9 (9.7) 38.3 (9.9) 0.01e
Female, n (%) 178 (65.2) 76 (52.4) 133 (45.6) <0.0001
Marital status, n (%)c
 Married 122 (44.7) 48 (33.3) 114 (39.9) 0.16
 Widow/widower 38 (13.9) 17 (11.8) 40 (14.0)  
 Divorced/separated 94 (34.4) 59 (41.0) 96 (33.5)  
 Single 19 (7.0) 19 (13.2) 34 (11.9)  
 Lives with partner 0 (0.0) 1 (0.7) 2 (0.7)  
Occupation, n (%)c
 Salaried 6 (2.2) 8 (5.6) 10 (3.5) 0.16
 Self-employed 237 (86.8) 119 (82.6) 251 (87.8)  
 Housewife 19 (7.0) 6 (4.1) 10 (3.5)  
 Student 2 (0.7) 3 (2.1) 1 (0.3)  
 Unemployed 9 (3.3) 8 (5.6) 14 (4.9)  
Education level, n (%)c
 None 81 (29.6) 31 (21.5) 82 (28.7) 0.01
 Primary 176 (64.5) 104 (72.2) 192 (67.1)  
 Secondary 16 (5.9) 5 (3.5) 11 (3.9)  
 University/Tertiary 0 (0) 4 (2.8) 1 (0.3)  
Social economic status, n (%)
 Lowest 58 (21.3) 19 (13.1) 64 (22.4) 0.10
 Low 64 (23.4) 24 (16.6) 62 (21.7)  
 Middle 54 (19.8) 28 (19.3) 50 (17.5)  
 High 47 (17.2) 39 (26.9) 55 (19.2)  
 Highest 50 (18.3) 35 (24.1) 55 (19.2)  
Fat mass index (kg/m2)d 2.9 (0.8) 2.7 (0.8) 2.5 (0.8) <0.0001f
Fat-free mass index (kg/m2)d 14.0 (0.9) 14.1 (0.8) 13.9 (1.0) 0.14
Body mass index (kg/m2) 16.7 (1.2) 16.7 (1.2) 16.2 (1.5) 0.0001g
CD4 count (cells/μL) 127 (99.7) 116 (102.8) 113 (106.8) 0.29
Tuberculosis treatment, n (%) 63 (23.1) 49 (33.8) 48 (16.8) <0.0001
  1. aData are mean ± SD unless specified as n (%)
  2. bcomparison done by oneway ANOVA test for continuous outcomes and chi-squared test for categorical outcomes
  3. c1 patient missing in the lost-to follow-up group
  4. d25 patients in the followed-up group, 16 in the lost to follow-up group, and 68 in the died group missing
  5. eBonferroni test showed differences between the followed-up group and the lost to follow-up group (P = 0.009) and the lost to follow-up group and the died group (P = 0.049)
  6. fBonferroni test showed differences between the followed-up group and the died group (P < 0.0001)
  7. gBonferroni test showed differences between the followed-up group and the died group (P < 0.0001) and the lost to follow-up group and the died group (P < 0.0001)